Sagimet Biosciences (SGMT) Share-based Compensation: 2023-2024
Historic Share-based Compensation for Sagimet Biosciences (SGMT) over the last 2 years, with Sep 2024 value amounting to $1.5 million.
- Sagimet Biosciences' Share-based Compensation fell 16.66% to $1.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.1 million, marking a year-over-year change of. This contributed to the annual value of $5.3 million for FY2024, which is 5.97% up from last year.
- Per Sagimet Biosciences' latest filing, its Share-based Compensation stood at $1.5 million for Q3 2024, which was up 6.69% from $1.4 million recorded in Q2 2024.
- Over the past 5 years, Sagimet Biosciences' Share-based Compensation peaked at $1.9 million during Q3 2023, and registered a low of $759,000 during Q1 2024.
- In the last 2 years, Sagimet Biosciences' Share-based Compensation had a median value of $1.3 million in 2023 and averaged $1.2 million.
- Examining YoY changes over the last 5 years, Sagimet Biosciences' Share-based Compensation showed a top increase of 37.09% in 2024 and a maximum decrease of 16.66% in 2024.
- Over the past 2 years, Sagimet Biosciences' Share-based Compensation (Quarterly) stood at $1.3 million in 2023, then decreased by 16.66% to $1.5 million in 2024.
- Its Share-based Compensation stands at $1.5 million for Q3 2024, versus $1.4 million for Q2 2024 and $759,000 for Q1 2024.